drugset / Trial / NCT01147432

Acute Response Capsaicin Flare Study

NCT01147432 ↗

Phase 1 Completed 12 enrolled Pfizer
RandomizedCrossoverDouble-blind

Summary

Prior to administering PF-04427429 to patients we wish to increase the understanding of functional effects associated with calcitonin gene related peptide (CGRP) pathways. This study will examine whether it is possible for a single dose of PF-04427429 to acutely attenuate a capsaicin induced flare response.

Timeline

Start
2010-08
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-04427429 Unknown 300 mg Intravenous

Indications

No indication recorded.